Pharmacy college job fairs play a critical role in bridging the gap between academia and industry. The fair provides a platform for pharmaceutical companies to communicate their hiring needs directly to students. This

Peter Koerte Siemens AG, said currently the U.S. is the company’s biggest market followed by China, Germany and France along with some neighbouring markets

It’s terrible feeling to lose hope and feel like our circumstances are hopeless. It’s not how we are meant to live, but we can lose sight of this because of what we are going through. Join Michael as he shares his thoughts and experiences on this very difficult topic and how we can maintain or recapture hope no matter what we are experiencing. Michael also shares some exciting developments occurring with Ancient Faith Ministries and the world of J.R.R. Tolkien, an author whose fiction deals a lot with hope amidst hopelessness.

These days, anyone can start a blog or create a simple website in a matter of hours. However, getting that website to work and look just the way you want it to takes a lot more time. Most people don’t realize that and end up giving up long before the work is done. If you don’t have […]

The post How to Create a Blog or a Freelance Writer’s Portfolio Using Propel Site appeared first on Leaving Work Behind.

This is a lecture from St. Vladimir's Seminary's annual Orthodox Education Day event, held this year on October 1, 2016. The speakers are the Sisters of All Saints Greek Orthodox Monastery, Long Island, New York.

Source: Streetwise Reports 11/08/2024

Vertex Pharmaceuticals Inc. (VRTX:NASDAQ) has reported a robust financial performance for the third quarter of 2024. The report has demonstrated the company's continued revenue growth and the strengthening of its innovative pipeline. For Q3 2024, Vertex's product revenue reached US$2.77 billion, a 12% increase from the previous year. This was primarily driven by strong demand for its TRIKAFTA®/KAFTRIO® therapies. Based on this momentum, Vertex raised its full-year product revenue guidance to a range of US$10.8 billion to US$10.9 billion, citing a solid trajectory in its cystic fibrosis (CF) portfolio and expected future launches.

In Q3, the company made notable advancements in its pipeline. Three programs have begun moving into Phase 3 clinical development: suzetrigine in diabetic peripheral neuropathy (DPN), povetacicept in IgA nephropathy (IgAN), and VX-880 in type 1 diabetes (T1D). Vertex is also preparing for the launch of two potential treatments in early 2025, with PDUFA dates set for January 2 for the vanzacaftor triple therapy for CF and January 30 for suzetrigine, the latter being a pain medication in a new therapeutic class aimed at reducing reliance on opioids.

GAAP and Non-GAAP net income both reached US$1.0 billion, largely driven by increased product revenue, which offset rising R&D and SG&A expense. This was s due to investments in global commercialization and late-stage clinical development. For Q3, Vertex's combined R&D and SG&A expenses were US$1.2 billion and US$1.1 billion, respectively, an increase from last year attributed to new global program advancements and upcoming launch support.

Vertex's cash position remained strong, with US$11.2 billion in cash, cash equivalents, and marketable securities as of September 30. The decline from US$13.7 billion at the end of 2023 primarily reflects the acquisition of Alpine Immune Sciences and share repurchases under the company's buyback program.

A Look At Biotechnology and Pharma

The U.S. Pharmaceuticals Report for 2024 by Nova One Advisor detailed the size and growth trajectory of the U.S. pharmaceutical market. Valued at US$602.19 billion in 2023, the sector is projected to exceed US$1 trillion by 2033. The report pointed to a "high healthcare expenditure provided by government bodies" as a primary growth driver, further bolstered by the aging population's demand for advanced treatments.

In an October 24 article, The Investing News Network reported on a dynamic landscape within the biotechnology sector. The report highlighted advancements in AI-powered drug discovery. Despite a cautious investment climate, interest remained strong in AI's potential to reshape healthcare, with venture capital investment reaching US$6.59 billion. At the HealthTech Ignite conference, Susie Roberts from Relay Therapeutics expressed confidence, noting, "We will definitely see AI design drugs in the next 10 years."

On November 4, Yahoo! Finance shared insights from MIT professors Andrew Lo and Dennis Whyte. They emphasized that biotechnology's rapid advancement over the past five decades offers valuable lessons for future innovation. In their research paper, Lo and Whyte proposed initiatives to accelerate biotechnology's growth, underscoring the importance of "reducing risk and uncertainty" to foster a robust investment ecosystem that supports groundbreaking discoveries.

Catalysts Driving Vertex Pharma

According to Vertex's November 2024 investor presentation, the company sees multiple growth catalysts over the next few years. Vertex aims to meet its goal of achieving "five launches in five years," focusing on expanding the treatable patient base in CF with vanzacaftor triple, addressing critical needs in sickle cell disease (SCD) and beta thalassemia (TDT) with CASGEVY, and launching suzetrigine for acute pain management.

Additionally, Vertex expects its expansive R&D pipeline to support long-term growth. This includes pivotal clinical trials for VX-880 in T1D, povetacicept in IgAN, and NaV1.8 pain inhibitors like suzetrigine, indicating a commitment to treating a range of chronic and life-threatening conditions with limited therapeutic options.

By driving advancements in CF therapies, diversifying its portfolio with novel pain treatments, and pursuing accelerated approvals for renal and blood-related disorders, Vertex is strategically positioning itself to sustain growth and achieve several near-term milestones.

What Are Experts Saying About Vertex?

In a November 5, 2024, H.C. Wainwright & Co. update, the analysts highlighted promising data from Vertex's recent Phase 2 trial for suzetrigine, which showed encouraging reductions in pain intensity. [OWNERSHIP_CHART-4085]

The analysts noted that suzetrigine's peripheral nervous system-specific mechanism could potentially address "a significant, unmet medical need worldwide" in non-opioid pain management. They set a price target of US$600.00, projecting Vertex's continued growth from its strong cystic fibrosis franchise and pipeline expansion.

From the November 7 Kingswood Capital Partners report, analysts noted Vertex Pharmaceuticals' "sustained execution" in advancing product development programs and achieving robust operating margins, enabling "continued, significant investments" in both its pipeline and commercial capabilities. The firm maintained a "Buy" rating with a 12-month target price of US$550.00, attributing this outlook to Vertex's deep cash resources and historical successes in clinical trials.

Ownership and Share Structure

According to Refinitiv, 95.44% of Vertex Pharmaceuticals is held by Institutions. The top among them are Capital World Investors at 10.37%, The Vanguard Group at 8.88%, BlackRock Institutional Trust with 5.49%, State Street Global Advisors (US) with 4.55%, and Fidelity Management and Research with 4.11%. Strategic Investors hold .12%. The rest is retail.

The company's market cap is US$129,395.59 million with 257.07 million free float shares. The 52 week range is US$341.90–$510.64.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

1) James Guttman wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.

2) This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

( Companies Mentioned: VRTX:NASDAQ, )

The G7 connected wearable from Blackline Safety (TSX.V: BLN) was one of five products highlighted by the Globe and Mail in their new Report on Business ranking of Canada’s Top Growing companies. Having earned position No. 231 on the ranking, Blackline achieved a three-year revenue growth of 145%.

Fine fast-casual Mediterranean concept ignites global expansion with the opening of its first international location in Canada.

Full-service promotional products franchise shares exciting brand updates and recognizes outstanding franchise owners at annual brand convention.

Signature Image Global School, the online academic institution affiliated with and stemming from Signature Image Academy International in Asia Singapore, announces the launch of its cutting-edge Advanced Diploma online learning programmes.

Unafraid to break the mold and bounce to a new beat

Challenges and Opportunities in the EV Charging Infrastructure Landscape

Jason Reynolds is an award-winning author and National Ambassador for Young People's Literature. This hour, Jason speaks with Manoush about reaching kids through stories that let them feel understood. This conversation is part of a collaboration between NPR and the Library of Congress National Book Festival. For more information about the festival visit loc.gov/bookfest

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Original broadcast date: September 17, 2021. Jason Reynolds is an award-winning author and National Ambassador for Young People's Literature. This hour, Jason speaks with Manoush about reaching kids through stories that let them feel understood.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Discovery may propel advances in regenerative medicineTORONTO, ON – Consider the relationship between an air traffic controller and a pilot. The pilot gets the passengers to their destination, but the air traffic controller decides when the plane can take off and when it must wait. The same relationship plays out at the cellular level in […]

Private equity funds managed by Blackstone Private Equity will purchase Emerson’s 40% common equity ownership in the joint venture, while Copeland will repurchase the seller’s note.

The Markham District Energy facility differs from standard applications because instead of relying on conventional energy sources, it captures waste heat from sewage, which enters at about 5°C and is converted into 95°C usable heat.

Ross B. Shuster, CEO, Copeland, discusses Blackstone’s investment into the company, how the transaction will impact the company’s HVAC offerings, and more.

Thanks to the prevalent use of online search engines like Google, consumers everywhere are becoming more educated on the products they buy, and HVAC systems are no exception.

The honor complements the Energy Star Partner of the Year Sustained Excellence award, which was announced earlier this year in the U.S.

When the Woosh air quality monitor and smart air filter are paired with a Sensi smart thermostat, users can transform an HVAC system into an air purifier for the entire home.

The Magnitude^® magnetic bearing centrifugal chillers from Daikin Applied not only reduce maintenance requirements and offer increased efficiencies, according to one Dealer Design Awards judge, but they also feature nearly nonexistent compressor vibration and top-tier customer support. 

JavaScript has been around since 1995. But a lot has changed in nearly a quarter-century. No longer limited to the browser, JavaScript has become a full fledged programming language, finding increasing use in enterprise application development. In this program we will explore the evolution of JavaScript , discuss how it is used in modern development projects, and then take a close look at Oracle JavaScript Extension Toolkit, otherwise known as JET.

View the complete show notes.

Equipter's new dump container was designed to fit into tighter spaces than its larger counterparts, and is capable of holding up to 2,500 lbs.

The Owens Corning booth at IRE highlights roofing products that fuse high-performance with beauty and style.

Importante aumento de tamaño en este todocamino, que mide ahora 4,66 metros. Se vende siempre electrificado y con unos precios que parten de los 32.400 euros. Leer

Los primeros indicios apuntan que el hombre tropezó en un intento de cruzar la vía cuando el semáforo estaba en rojo para él Leer

El siniestro ocurrió sobre las 4:15 horas en la calle Alberto Alcocer, a la altura del número 37 Leer

El conductor, de 62 años, ha sido detenido y no está claro en un primer momento si se trata de un ataque o un accidente Leer

La víctima iba en bicicleta en el casco urbano y el conductor la ha arrollado y se ha dado a la fuga Leer

El hombre ha perdido el control de su vehículo y ha acabado invadiendo una zona peatonal Leer

La víctima participaba en una operación contra un grupo de 'petaqueros', los encargados de suministras combustible a los narcolanchas Leer

Location: Electronic Resource- 

Machines of Loving Grace Anthropic CEO Dario Amodei publishes a 14,000-word post on How AI Could Transform the World for the Better, detailing how the 5-10 years following availability of an "Expert-Level Science and Engineering" AI, or "country of geniuses in a datacenter" will play out advances in biology, (Amodei's specialty,) neuroscience, economic development, governance, and work and meaning. Amodei draws on Iain M. Bank's MeFi Favorite the Culture as he concludes: "I think the Culture's values are a winning strategy because they're the sum of a million small decisions that have clear moral force and that tend to pull everyone together onto the same side. Basic human intuitions of fairness, cooperation, curiosity, and autonomy are hard to argue with, and are cumulative in a way that our more destructive impulses often aren't. [...] These simple intuitions, if taken to their logical conclusion, lead eventually to rule of law, democracy, and Enlightenment values. If not inevitably, then at least as a statistical tendency, this is where humanity was already headed. AI simply offers an opportunity to get us there more quickly—to make the logic starker and the destination clearer. Banks, most previously on the Blue: [1][2] via The Verge/Decoder

John Freddy Bernal, padre de la mujer atropellada en Perú, estuvo en 10AM Hoy por Hoy de Caracol Radio hablando sobre el martirio que ha pasado con este tema.

En 6AM Hoy por Hoy de Caracol Radio estuvo Germán Córdoba, director del partido político Cambio Radical, para hablar sobre la acción del Gobierno de intervenir a la EPS Sánitas.

Putting humans on Mars has been one of NASA’s driving missions for years, but they are still in the early stages of deciding what exactly that mission architecture will look like. One major factor is where to get the propellant to send the astronauts back to Earth. Advocates of space exploration often suggest harvesting the …

Continue reading "Scaling Propellant Production on Mars is Hard"

The post Scaling Propellant Production on Mars is Hard appeared first on Universe Today.

When 3D printing first took off, it was difficult to imagine how diverse the field would grow. Nowadays, the realm of additive manufacturing is growing daily. In particular, five sectors are advancing rapidly as a result of developments in additive manufacturing. These are healthcare, food, fashion, motorsports and aerospace. Based on estimates, it is believed that soon these industries will incorporate 3D printing as a key component of their operations.[...]

Credit: Leftwich Lab

​​​​​​​Jocelyne Larocque scored less than 4 minutes into the game, Sarah Nurse added a goal midway through the first period and Canada cruised to a 4-1 win over the United States in Boston on Sunday to take a 2-1 lead in the five-game Rivalry Series.

The Federation of Pharmaceutical Entrepreneurs (FOPE) has identified potential opportunities for Indian pharmaceutical companies to expand in Australia. Further, the India─Australia Economic Cooperation and Trade

The Police drummer Stewart Copeland answers the internet's burning questions about playing the drums. What is the most difficult song to drum? What's the best way for a beginner to learn how to drum fill? Who's the best drummer he's ever seen live? Stewart answers all these questions and much, much more!Available in three distinct, deluxe editions, Stewart Copelands Police Diaries is now available. https://policediariesbook.com/Director: Justin WolfsonDirector of Photography: Francis BernalEditor: Richard TrammellTalent: Stewart CopelandLine Producer: Joseph BuscemiAssociate Producer: Brandon WhiteProduction Manager: D. Eric MartinezProduction Coordinator: Fernando DavilaTalent Booker: Paige Garbarini, Meredith JudkinsCamera Operator: CloudGaffer: Rebecca Van Der MeulenSound Mixer: Sean PaulsenProduction Assistant: Noah BierbrierPost Production Supervisor: Alexa DeutschPost Production Coordinator: Ian BryantSupervising Editor: Doug LarsenAdditional Editor: Paul TaelAssistant Editor: Billy Ward

BJP’s third term pledges support for space, AI and warehousing; Next-generation reforms agenda to touch all factors of production including digital infrastructure

How far the reduction in repo rate is going to help the home loan segment remains to be seen. By K. Sukumaran

Self-declaration, simple policies and quick decisions, says Sunil Duggal, CEO, Hindustan Zinc